Mizuho Issues Positive Forecast for Solventum (NYSE:SOLV) Stock Price

Solventum (NYSE:SOLV) had its price objective boosted by Mizuho from $70.00 to $82.00 in a research report sent to investors on Monday morning,Benzinga reports. They currently have a neutral rating on the stock.

SOLV has been the topic of several other reports. Wells Fargo & Company lifted their price objective on Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a report on Friday. The Goldman Sachs Group upped their price target on shares of Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a report on Monday. Piper Sandler boosted their target price on shares of Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a research report on Friday. Morgan Stanley increased their price target on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. Finally, Bank of America upped their price objective on Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a research note on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $78.86.

Solventum Stock Performance

Solventum stock opened at $80.07 on Monday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The firm’s fifty day moving average price is $72.78 and its 200 day moving average price is $70.20. The company has a market capitalization of $13.83 billion and a price-to-earnings ratio of 29.12. Solventum has a 12-month low of $47.16 and a 12-month high of $85.92.

Institutional Trading of Solventum

Large investors have recently added to or reduced their stakes in the business. Modus Advisors LLC bought a new stake in Solventum in the fourth quarter worth about $25,000. Clarity Asset Management Inc. acquired a new stake in shares of Solventum during the 4th quarter valued at about $25,000. Stonebridge Financial Group LLC acquired a new position in shares of Solventum during the 4th quarter worth $26,000. Raiffeisen Bank International AG bought a new stake in Solventum during the fourth quarter valued at about $29,000. Finally, True Wealth Design LLC grew its stake in shares of Solventum by 23,550.0% in the third quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after acquiring an additional 471 shares during the last quarter.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.